Columbia Partners L L C Investment Management purchased a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 68,350 shares of the company’s stock, valued at approximately $3,375,000. Columbia Partners L L C Investment Management owned 0.08% of Acadia Healthcare at the end of the most recent quarter.
Other large investors have also bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Acadia Healthcare by 11.1% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock valued at $134,000 after buying an additional 270 shares during the period. Riverhead Capital Management LLC purchased a new position in Acadia Healthcare in the second quarter valued at about $209,000. Paloma Partners Management Co purchased a new position in Acadia Healthcare in the first quarter valued at about $217,000. M&T Bank Corp purchased a new position in Acadia Healthcare in the first quarter valued at about $230,000. Finally, World Asset Management Inc purchased a new position in Acadia Healthcare in the second quarter valued at about $242,000.
A number of research analysts have commented on the company. Mizuho boosted their target price on Acadia Healthcare from $57.00 to $60.00 and gave the company a “buy” rating in a research note on Friday, July 28th. Zacks Investment Research downgraded Acadia Healthcare from a “buy” rating to a “hold” rating in a research note on Tuesday, August 1st. Craig Hallum restated a “buy” rating and issued a $65.00 target price (up previously from $52.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. Deutsche Bank AG boosted their target price on Acadia Healthcare from $58.00 to $60.00 and gave the company a “buy” rating in a research note on Monday, July 31st. Finally, UBS AG restated a “positive” rating and issued a $60.00 target price (up previously from $54.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. One investment analyst has rated the stock with a sell rating, four have given a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. Acadia Healthcare currently has a consensus rating of “Buy” and an average target price of $58.69.
In related news, insider Scott Schwieger sold 2,891 shares of Acadia Healthcare stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $52.85, for a total transaction of $152,789.35. Following the completion of the transaction, the insider now owns 8,841 shares in the company, valued at $467,246.85. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Christopher L. Howard sold 53,713 shares of Acadia Healthcare stock in a transaction dated Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total value of $2,722,711.97. Following the transaction, the executive vice president now owns 147,286 shares of the company’s stock, valued at approximately $7,465,927.34. The disclosure for this sale can be found here. Insiders have sold 3,185,693 shares of company stock valued at $162,606,599 in the last quarter. 11.10% of the stock is currently owned by corporate insiders.
ILLEGAL ACTIVITY WARNING: This news story was first reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.chaffeybreeze.com/2017/09/18/68350-shares-in-acadia-healthcare-company-inc-achc-acquired-by-columbia-partners-l-l-c-investment-management.html.
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) traded up 0.374% during trading on Monday, hitting $46.955. The company had a trading volume of 228,954 shares. The stock has a 50-day moving average of $48.96 and a 200-day moving average of $45.91. The stock has a market capitalization of $4.13 billion, a PE ratio of 515.989 and a beta of 1.14. Acadia Healthcare Company, Inc. has a one year low of $32.54 and a one year high of $54.34.
Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Thursday, July 27th. The company reported $0.66 EPS for the quarter, topping analysts’ consensus estimates of $0.65 by $0.01. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The business had revenue of $715.90 million during the quarter, compared to analysts’ expectations of $717.38 million. During the same quarter last year, the company posted $0.73 earnings per share. Acadia Healthcare’s quarterly revenue was down 5.4% on a year-over-year basis. On average, equities analysts anticipate that Acadia Healthcare Company, Inc. will post $2.45 EPS for the current year.
Acadia Healthcare Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC).
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.